Frazier Management’s Gritstone bio GRTS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q4
$60M Hold
4,667,242
– – 4.62% 5
2021
Q3
$50.4M Buy
4,667,242
+3,636,364
+353% +$33.1M 4.03% 8
2021
Q2
$9.41M Hold
1,030,878
– – 0.87% 21
2021
Q1
$9.7M Sell
1,030,878
-1,030,880
-50% -$14.2M 0.78% 21
2020
Q4
$8.12M Hold
2,061,758
– – 0.63% 24
2020
Q3
$5.46M Hold
2,061,758
– – 0.49% 19
2020
Q2
$13.7M Hold
2,061,758
– – 1.2% 15
2020
Q1
$12M Hold
2,061,758
– – 1.36% 11
2019
Q4
$18.5M Hold
2,061,758
– – 3.1% 7
2019
Q3
$17.8M Hold
2,061,758
– – 5.57% 7
2019
Q2
$23M Hold
2,061,758
– – 5.89% 5
2019
Q1
$27.4M Hold
2,061,758
– – 6.6% 4
2018
Q4
$31.9M Sell
2,061,758
-4
-0% -$76 8.22% 4
2018
Q3
$29.4M Buy
+2,061,762
New +$29.4M 5.38% 4

Other funds holding GRTS

Frazier Management's GRTS Position: Q4 2021 in Review

Frazier Management held its Gritstone bio (GRTS) position steady in Q4 2021 at 4,667,242 shares worth $60M. The position accounts for 4.62% of the portfolio, ranked #5.

Frazier Management first reported a position in GRTS in Q3 2018 and has held it in 14 quarters since. 115 funds tracked by Wall St. Rank hold GRTS as of Q4 2021.

  • Frazier Management held 4,667,242 shares of Gritstone bio worth $60M as of Q4 2021.
  • Frazier Management left its Gritstone bio share count unchanged in Q4 2021.
  • Gritstone bio made up 4.62% of Frazier Management's portfolio in Q4 2021, its #5 holding.
  • Frazier Management first reported a position in Gritstone bio in Q3 2018 and has held it in 14 quarters since.
  • 115 funds tracked by Wall St. Rank held Gritstone bio as of Q4 2021.

Based on Frazier Management's 13F filing for Q4 2021, filed 8 Feb 2022.